The GZF1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the HT29 human colorectal adenocarcinoma cell line, in which the GZF1 locus has been disrupted to create a heterogeneous loss-of-function model. This polyclonal cell product provides a genetically diverse pool of knockout cells that reflects the variability of bulk gene editing, making it suitable for robust functional analyses. The cells are delivered as a ready-to-propagate population for immediate use in a variety of molecular and cellular assays.
The parental HT29 cell line was established from a primary colon adenocarcinoma of a 44-year-old female and is extensively employed as a model for colorectal cancer research. HT29 cells exhibit an epithelial phenotype and retain the capacity for enterocytic differentiation and mucin production under appropriate culture conditions. Genomically, they carry wild-type p53 and truncated APC tumor suppressor proteins, mirroring key molecular alterations found in sporadic colorectal tumors. This well-characterized background makes HT29 an ideal host for interrogating genes that modulate Wnt pathway activity and colorectal tumorigenesis.
GZF1 encodes a zinc finger transcription factor that functions as a negative regulator of the Wnt/??-catenin signaling pathway. Mechanistically, GZF1 physically interacts with ??-catenin (CTNNB1) and facilitates its ubiquitination and proteasomal degradation, thereby attenuating ??-catenin/TCF4 transcriptional activity. Loss of GZF1 therefore results in elevated ??-catenin levels, enhanced TCF4-mediated transcription, and upregulation of proliferation-associated targets such as MYC, CCND1, and AXIN2. Additionally, GZF1 transcriptionally represses CDKN1A, and its expression is regulated upstream by the GDNF/RET signaling axis through the GFR??1/RET receptor complex. GZF1 also recruits N-CoR/SMRT co-repressors to gene regulatory elements, underscoring its role as a transcriptional repressor at multiple levels.
In the context of the HT29 colorectal adenocarcinoma, which harbors APC mutations that constitutively activate Wnt signaling, disruption of GZF1 further derepresses ??-catenin/TCF4-dependent oncogenic programs. This synergy intensifies the transformed phenotype and establishes the GZF1 Knockout HT29 Polyclonal Cells as a powerful system for dissecting the interplay between the APC destruction complex and GZF1-mediated negative regulation. The polyclonal nature of the population also allows the study of clonal heterogeneity, differentiation dynamics, and mucinous secretion in a colorectal cancer setting.
These polyclonal knockout cells are suited for colorectal cancer research applications such as Wnt pathway reporter assays (TOP/FOP Flash), RT-qPCR or RNA-seq profiling, and cell proliferation analysis via MTT or BrdU. Apoptosis, migration, and colony formation assays are also readily performed. Co-immunoprecipitation can probe interactions with ??-catenin, TCF4, or N-CoR/SMRT. The cells enable drug response studies with Wnt inhibitors or chemotherapeutics. For inquiries, contact Ascent Research.
